These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22906178)

  • 1. Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes.
    Pepin F; Bertos N; Laferrière J; Sadekova S; Souleimanova M; Zhao H; Finak G; Meterissian S; Hallett MT; Park M
    Breast Cancer Res; 2012 Aug; 14(4):R120. PubMed ID: 22906178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.
    Wang JC; Li GY; Wang B; Han SX; Sun X; Jiang YN; Shen YW; Zhou C; Feng J; Lu SY; Liu JL; Wang MD; Liu PJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):235. PubMed ID: 31164151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.
    Myhre S; Mohammed H; Tramm T; Alsner J; Finak G; Park M; Overgaard J; Børresen-Dale AL; Frigessi A; Sørlie T
    PLoS One; 2010 Nov; 5(11):e14002. PubMed ID: 21124964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.
    Lopes N; Sousa B; Vieira D; Milanezi F; Schmitt F
    Histopathology; 2009 Nov; 55(5):594-9. PubMed ID: 19912365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis.
    Harrell JC; Pfefferle AD; Zalles N; Prat A; Fan C; Khramtsov A; Olopade OI; Troester MA; Dudley AC; Perou CM
    Clin Exp Metastasis; 2014 Jan; 31(1):33-45. PubMed ID: 23975155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
    Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
    Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases.
    Harrell JC; Dye WW; Harvell DM; Sartorius CA; Horwitz KB
    Clin Exp Metastasis; 2008; 25(1):81-8. PubMed ID: 17932773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.
    Dai X; Li Y; Bai Z; Tang XQ
    Sci Rep; 2015 Sep; 5():14499. PubMed ID: 26404658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.
    Patsialou A; Wang Y; Lin J; Whitney K; Goswami S; Kenny PA; Condeelis JS
    Breast Cancer Res; 2012 Oct; 14(5):R139. PubMed ID: 23113900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
    Lyng MB; Laenkholm AV; Pallisgaard N; Vach W; Knoop A; Bak M; Ditzel HJ
    Cell Oncol; 2007; 29(5):361-72. PubMed ID: 17726259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour angiogenesis and c-Met pathway activation - implications in breast cancer.
    Mitra S; Bal A; Kashyap D; Kumar S; Shrivastav S; Das A; Singh G
    APMIS; 2020 Apr; 128(4):316-325. PubMed ID: 31991499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.
    Tchou J; Kossenkov AV; Chang L; Satija C; Herlyn M; Showe LC; Puré E
    BMC Med Genomics; 2012 Sep; 5():39. PubMed ID: 22954256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.